谱尼测试(300887) - 2022 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2022 reached ¥533,503,557.47, representing a 71.21% increase compared to ¥311,601,470.04 in the same period last year[3] - Net profit attributable to shareholders was ¥5,511,208.06, a significant turnaround from a loss of ¥42,567,499.50 in the previous year, marking a 112.95% improvement[3] - The net profit after deducting non-recurring gains and losses was ¥10,548,370.87, compared to a loss of ¥49,672,628.14 last year, reflecting a 121.24% increase[3] - Operating profit for the quarter was ¥12,681,195.66, compared to an operating loss of ¥41,554,864.98 in the previous year[25] - The company reported a total comprehensive income of ¥5,579,318.07, recovering from a loss of ¥42,569,929.54 in the previous year[26] - The basic and diluted earnings per share were both ¥0.0402, compared to a loss per share of ¥0.3112 in Q1 2021[26] Assets and Liabilities - The total assets at the end of Q1 2022 amounted to ¥4,228,037,046.53, a 52.05% increase from ¥2,780,683,964.60 at the end of the previous year[3] - The company's total equity rose to ¥3,263,155,109.93, compared to ¥2,019,999,602.53 in the previous year, marking a growth of 61.5%[23] - Total liabilities increased to ¥964,881,936.60, up from ¥760,684,362.07 year-on-year, reflecting a growth of 26.8%[23] - The company's total liabilities increased, with accounts payable rising by 49.82% to ¥210,728,412.57, reflecting growth in operational scale[9] Cash Flow - The company's cash flow from operating activities showed an improvement, with a net outflow of ¥75,269,395.38, which is 37.95% less than the outflow of ¥121,307,300.07 in the same period last year[3] - Operating cash inflow for Q1 2022 was $494.09 million, an increase of 64.73% compared to $299.94 million in Q1 2021, primarily due to the collection of receivables[11] - Operating cash outflow for Q1 2022 was $569.36 million, up 35.16% from $421.25 million in Q1 2021, driven by increased payments for goods and services due to business growth[11] - Net cash flow from operating activities improved to -$75.27 million in Q1 2022, a 37.95% improvement from -$121.31 million in Q1 2021[11] - Cash and cash equivalents increased by 853.75% to $1.11 billion in Q1 2022, compared to a decrease of $147.72 million in Q1 2021[11] - Total cash and cash equivalents at the end of Q1 2022 reached $1.61 billion, a 211.28% increase from $518.57 million at the end of Q1 2021[11] Investment Activities - The company reported a significant decrease in investment cash inflow, which was $0 in Q1 2022 compared to $136.49 million in Q1 2021, due to the absence of matured financial products[11] - Investment cash outflow decreased by 41.77% to $94.85 million in Q1 2022 from $162.90 million in Q1 2021, primarily due to reduced purchases of financial products[11] - The total cash outflow from investing activities was 94,853,706.42, compared to 162,897,536.00 in the previous year, indicating a reduction in investment spending[29] - The company did not report any cash inflow from investment activities, contrasting with 136,493,132.66 in the previous year[29] Research and Development - Research and development expenses increased by 52.58% to ¥44,169,647.67, indicating a focus on enhancing innovation and product development[10] - Research and development expenses increased to ¥44,169,647.67, up from ¥28,948,546.80, reflecting a growth of 52.5%[25] - The company’s technology center was recognized as a national enterprise technology center, aiming to enhance its innovation capabilities[18] Acquisitions and Market Expansion - The company completed the acquisition of Shenzhen Tongce Testing Technology Co., Ltd., resulting in a long-term equity investment of ¥9,800,000.00[9] - The company acquired 70% of Shenzhen Tongce Testing Technology Co., Ltd. for RMB 49 million, enhancing its presence in the South China electronic testing market[18] - The company’s subsidiary in Inner Mongolia received approval to conduct clinical genetic testing, expanding its medical testing capabilities[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,261, with the largest shareholder holding 52.20% of the shares[13] - The company raised RMB 1,239,752,451.00 by issuing 22,418,670 shares at a price of RMB 55.30 each[17] Miscellaneous - The company plans to utilize up to RMB 700 million of idle funds for cash management without affecting investment plans[17] - The impact of exchange rate changes on cash and cash equivalents was a decrease of -7,529.88[29] - The first quarter report was not audited[30]